Literature DB >> 28228490

Short-Read Whole-Genome Sequencing for Laboratory-Based Surveillance of Bordetella pertussis.

Alex Marchand-Austin1,2, Raymond S W Tsang3, Jennifer L Guthrie2, Jennifer H Ma2, Gillian H Lim4, Natasha S Crowcroft5,4,6, Shelley L Deeks4,6, David J Farrell5,2, Frances B Jamieson5,2.   

Abstract

Bordetella pertussis is a Gram-negative bacterium that causes respiratory infections in humans. Ongoing molecular surveillance of B. pertussis acellular vaccine (aP) antigens is critical for understanding the interaction between evolutionary pressures, disease pathogenesis, and vaccine effectiveness. Methods currently used to characterize aP components are relatively labor-intensive and low throughput. To address this challenge, we sought to derive aP antigen genotypes from minimally processed short-read whole-genome sequencing data generated from 40 clinical B. pertussis isolates and analyzed using the SRST2 bioinformatic package. SRST2 was able to identify aP antigen genotypes for all antigens with the exception of pertactin, possibly due to low read coverage in GC-rich low-complexity regions of variation. Two main genotypes were observed in addition to a singular third genotype that contained an 84-bp deletion that was identified by SRST2 despite the issues in allele calling. This method has the potential to generate large pools of B. pertussis molecular data that can be linked to clinical and epidemiological information to facilitate research of vaccine effectiveness and disease severity in the context of emerging vaccine antigen-deficient strains.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Bordetella pertussis; DNA sequencing; immunization; molecular methods; surveillance studies

Mesh:

Substances:

Year:  2017        PMID: 28228490      PMCID: PMC5405262          DOI: 10.1128/JCM.02436-16

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  35 in total

1.  Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology.

Authors:  F R Mooi; H Hallander; C H Wirsing von König; B Hoet; N Guiso
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-03       Impact factor: 3.267

2.  Genomic analysis of isolates from the United Kingdom 2012 pertussis outbreak reveals that vaccine antigen genes are unusually fast evolving.

Authors:  Katie L Sealey; Simon R Harris; Norman K Fry; Laurence D Hurst; Andrew R Gorringe; Julian Parkhill; Andrew Preston
Journal:  J Infect Dis       Date:  2014-12-08       Impact factor: 5.226

3.  Pertactin deficient Bordetella pertussis present a better fitness in mice immunized with an acellular pertussis vaccine.

Authors:  N Hegerle; G Dore; N Guiso
Journal:  Vaccine       Date:  2014-10-11       Impact factor: 3.641

4.  California pertussis epidemic, 2010.

Authors:  Kathleen Winter; Kathleen Harriman; Jennifer Zipprich; Robert Schechter; John Talarico; James Watt; Gilberto Chavez
Journal:  J Pediatr       Date:  2012-07-21       Impact factor: 4.406

5.  Pertactin-negative Bordetella pertussis strains in Canada: characterization of a dozen isolates based on a survey of 224 samples collected in different parts of the country over the last 20 years.

Authors:  Raymond S W Tsang; Michelle Shuel; Frances B Jamieson; Steven Drews; Linda Hoang; Greg Horsman; Brigitte Lefebvre; Shalini Desai; Monique St-Laurent
Journal:  Int J Infect Dis       Date:  2014-09-22       Impact factor: 3.623

6.  Comparison of 13 acellular pertussis vaccines: adverse reactions.

Authors:  M D Decker; K M Edwards; M C Steinhoff; M B Rennels; M E Pichichero; J A Englund; E L Anderson; M A Deloria; G F Reed
Journal:  Pediatrics       Date:  1995-09       Impact factor: 7.124

7.  Novel duplex real-time PCR assay detects Bordetella holmesii in specimens from patients with Pertussis-like symptoms in Ontario, Canada.

Authors:  J L Guthrie; A V Robertson; P Tang; F Jamieson; S J Drews
Journal:  J Clin Microbiol       Date:  2010-02-24       Impact factor: 5.948

8.  Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution.

Authors:  F R Mooi; H van Oirschot; K Heuvelman; H G van der Heide; W Gaastra; R J Willems
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

9.  Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan.

Authors:  Nao Otsuka; Hyun-Ja Han; Hiromi Toyoizumi-Ajisaka; Yukitsugu Nakamura; Yoshichika Arakawa; Keigo Shibayama; Kazunari Kamachi
Journal:  PLoS One       Date:  2012-02-14       Impact factor: 3.240

Review 10.  Pertussis resurgence: waning immunity and pathogen adaptation - two sides of the same coin.

Authors:  F R Mooi; N A T Van Der Maas; H E De Melker
Journal:  Epidemiol Infect       Date:  2013-02-13       Impact factor: 4.434

View more
  2 in total

1.  Comparative genomics of whole-cell pertussis vaccine strains from India.

Authors:  Shweta Alai; Vikas C Ghattargi; Manish Gautam; Krunal Patel; Shrikant P Pawar; Dhiraj P Dhotre; Umesh Shaligram; Sunil Gairola
Journal:  BMC Genomics       Date:  2020-05-07       Impact factor: 3.969

2.  Tatajuba: exploring the distribution of homopolymer tracts.

Authors:  Leonardo de Oliveira Martins; Samuel Bloomfield; Emily Stoakes; Andrew J Grant; Andrew J Page; Alison E Mather
Journal:  NAR Genom Bioinform       Date:  2022-02-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.